Expression and localization of mitochondrial ferritin mRNA in Alzheimer's disease cerebral cortex

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Wang, Ligang ^a,b   Yang, Hongkuan ^b   Zhao, Shiguang ^b   Sato, Haruhisa ^c   Konishi, Yoshihiro ^d   Beach, Thomas G ^e   Abdelalim, Essam Mohamed ^a   Bisem, Naomi J ^a   Tooyama, Ikuo ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c Marutamachi Hospital   (Japan)

^d National Tottori Medical Center   (Japan)

^e Civin Laboratory for Neuropathology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; FERRITIN; MESSENGER RNA; MITOCHONDRIAL FERRITIN; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); HYDROGEN PEROXIDE; PEPTIDE FRAGMENT;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IN SITU HYBRIDIZATION; NEUROPATHOLOGY; NEUROPROTECTION; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; CASE CONTROL STUDY; CELL DEATH; CHEMISTRY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PROTEIN MULTIMERIZATION; PROTEIN SECONDARY STRUCTURE; PROTEIN TRANSPORT; TUMOR CELL LINE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELL DEATH; CELL LINE, TUMOR; CEREBRAL CORTEX; GENE EXPRESSION REGULATION; HUMANS; HYDROGEN PEROXIDE; IN SITU HYBRIDIZATION; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY; PROTEIN TRANSPORT; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 79960575322     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022325     Document Type: Article

References (43)

1. LeVine SM, (1997) Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Res 760: 298-303.
2. Deibel MA, Ehmann WD, Markesbery WR, (1996) Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress. J Neurol Sci 143: 137-142.
3. Connor JR, Menzies SL, St Martin SM, Mufson EJ, (1992) A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J Neurosci Res 31: 75-83.
4. Smith MA, Harris PL, Sayre LM, Perry G, (1997) Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci U S A 94: 9866-9868.
5. Yamamoto A, Shin RW, Hasegawa K, Naiki H, Sato H, et al. (2002) Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer's disease. J Neurochem 82: 1137-1147.
6. Jefferies WA, Food MR, Gabathuler R, Rothenberger S, Yamada T, et al. (1996) Reactive microglia specifically associated with amyloid plaques in Alzheimer's disease brain tissue express melanotransferrin. Brain Res 712: 122-126.
7. Kawamata T, Tooyama I, Yamada T, Walker DG, McGeer PL, (1993) Lactotransferrin immunocytochemistry in Alzheimer and normal human brain. Am J Pathol 142: 1574-1585.
8. Wang L, Sato H, Zhao S, Tooyama I, (2010) Deposition of lactoferrin in fibrillar-type senile plaques in the brains of transgenic mouse models of Alzheimer's disease. Neurosci Lett 481: 164-167.
9. Castellani RJ, Moreira PI, Liu G, Dobson J, Perry G, et al. (2007) Iron: the Redox-active center of oxidative stress in Alzheimer disease. Neurochem Res 32: 1640-1645.
10. Altamura S, Muckenthaler MU, (2009) Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis. J Alzheimers Dis 16: 879-895.
11. Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, et al. (2001) Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 21: 3017-3023.
12. Kell DB, (2010) Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples. Arch Toxicol 84: 825-889.
13. Ponka P, (1997) Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. Blood 89: 1-25.
14. Napier I, Ponka P, Richardson DR, (2005) Iron trafficking in the mitochondrion: novel pathways revealed by disease. Blood 105: 1867-1874.
15. Arosio P, Levi S, (2010) Cytosolic and mitochondrial ferritins in the regulation of cellular iron homeostasis and oxidative damage. Biochim Biophys Acta 1800: 783-792.
16. Richardson DR, Lane DJ, Becker EM, Huang ML, Whitnall M, et al. (2010) Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol. Proc Natl Acad Sci U S A 107: 10775-10782.
17. Levi S, Corsi B, Bosisio M, Invernizzi R, Volz A, et al. (2001) A human mitochondrial ferritin encoded by an intronless gene. J Biol Chem 276: 24437-24440.
18. Drysdale J, Arosio P, Invernizzi R, Cazzola M, Volz A, et al. (2002) Mitochondrial ferritin: a new player in iron metabolism. Blood Cells Mol Dis 29: 376-383.
19. Levi S, Arosio P, (2004) Mitochondrial ferritin. Int J Biochem Cell Biol 36: 1887-1889.
20. Santambrogio P, Biasiotto G, Sanvito F, Olivieri S, Arosio P, et al. (2007) Mitochondrial ferritin expression in adult mouse tissues. J Histochem Cytochem 55: 1129-1137.
21. Pandolfo M, Pastore A, (2009) The pathogenesis of Friedreich ataxia and the structure and function of frataxin. J Neurol 256 (Suppl 1): 9-17.
22. Snyder AM, Wang X, Patton SM, Arosio P, Levi S, et al. (2009) Mitochondrial ferritin in the substantia nigra in restless legs syndrome. J Neuropathol Exp Neurol 68: 1193-1199.
23. Beach TG, Sue LI, Walker DG, Roher AE, Lue L, et al. (2008) The Sun Health Research Institute Brain Donation Program: description and experience, 1987-2007. Cell Tissue Bank 9: 229-245.
24. Beach TG, Sue LI, Scott S, Sparks DL, (1998) Neurofibrillary tangles are constant in aging human nucleus basalis. Alzheimer's report 6: 375-380.
25. An L, Sato H, Konishi Y, Walker DG, Beach TG, et al. (2009) Expression and localization of lactotransferrin messenger RNA in the cortex of Alzheimer's disease. Neurosci Lett 452: 277-280.
26. Tooyama I, Sato H, Yasuhara O, Kimura H, Konishi Y, et al. (2001) Correlation of the expression level of C1q mRNA and the number of C1q-positive plaques in the Alzheimer Disease temporal cortex. analysis of C1q mrna and its protein using adjacent or nearby sections. Dement Geriatr Cogn Disord 12: 237-242.
27. Gong Y, Chang L, Viola KL, Lacor PN, Lambert MP, et al. (2003) Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci U S A 18: 10417-22.
28. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, et al. (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A 95: 6448-6453.
29. Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, et al. (2007) Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci 27 (4): 796-807.
30. Chromy BA, Nowak RJ, Lambert MP, Viola KL, Chang L, et al. (2003) Self-assembly of Abeta(1-42) into globular neurotoxins. Biochemistry 42 (44): 12749-60.
31. Lacor PN, Buniel MC, Chang L, Fernandez SJ, Gong Y, et al. (2004) Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J Neurosci 24 (45): 10191-200.
32. Georganopoulou DG, Chang L, Nam JM, Thaxton CS, Mufson EJ, et al. (2005) Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease. Proc Natl Acad Sci U S A 102 (7): 2273-6.
33. Lambert MP, Viola KL, Chromy BA, Chang L, Morgan TE, et al. (2001) Vaccination with soluble Abeta oligomers generates toxicity- neutralizing antibodies. J Neurochem 79 (3): 595-605.
34. Klein WL, (2002) Abeta toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets. Neurochem Int 41 (5): 345-52.
35. Yanagisawa D, Taguchi H, Yamamoto A, Shirai N, Hirao K, et al. (2011) Curcuminoid binds to amyloid ß (1-42) oligomers and fibril. J Alzheimers Dis in press.
36. Saeki Makio, Kamisaki Yoshinori, Maeda Sadaaki, (2000) Involvement of mitogen-activated protein kinase in peroxynitrite-induced cell death of human neuroblastoma SH-SY5Y cells. Neuroscience Research 38: 213-216.
37. Halliwell B, (1992) Reactive oxygen species and the central nervous system. J Neurochem 59: 1609-1623.
38. Bush AI, (2003) Copper, zinc, and the metallobiology of Alzheimer disease. Alzheimer Dis Assoc Disord 17: 147-150.
39. Duce JA, Bush AI, (2010) Biological metals and Alzheimer's disease: implications for therapeutics and diagnostics. Prog Neurobiol 92: 1-18.
40. Duce JA, Tsatsanis A, Cater MA, James SA, Robb E, et al. (2010) Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell 142: 857-67.
41. Corsi B, Cozzi A, Arosio P, Drysdale J, Santambrogio P, et al. (2002) Human mitochondrial ferritin expressed in HeLa cells incorporates iron and affects cellular iron metabolism. J Biol Chem 277: 22430-22437.
42. Campanella A, Rovelli E, Santambrogio P, Cozzi A, Taroni F, et al. (2009) Mitochondrial ferritin limits oxidative damage regulating mitochondrial iron availability: hypothesis for a protective role in Friedreich ataxia. Hum Mol Genet 18: 1-11.
43. Nie G, Sheftel AD, Kim SF, Ponka P, (2005) Overexpression of mitochondrial ferritin causes cytosolic iron depletion and changes cellular iron homeostasis. Blood 105: 2161-2167.